Aimei Health Technology Co., Ltd (AFJK) vs DT Cloud Star Acquisition Corporation (DTSQ)
A side-by-side comparison of Aimei Health Technology Co., Ltd and DT Cloud Star Acquisition Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AFJK
Aimei Health Technology Co., Ltd
$12.39Financial ServicesDelayed quote: Oct 6, 2026, 11:28 AM EDT
DTSQ
DT Cloud Star Acquisition Corporation
$11.46Financial ServicesDelayed quote: Oct 6, 2026, 11:09 AM EDT
Total return — AFJK vs DTSQ
growth of $100 · dividends reinvested · last 2yAFJK +17.8% (+8.6%/yr)DTSQ +16.1% (+7.8%/yr)AFJK compounded faster over this window
AFJK DTSQ
AFJK vs DTSQ: by the numbers
- •DTSQ is the larger company ($42M vs $39M market cap).
- •DTSQ trades at the lower trailing earnings multiple (75.30 vs 181.67 P/E), one valuation lens rather than an overall verdict.
Metrics side by side
Valuation
| Metric | AFJK | DTSQ |
|---|---|---|
| P/E ratio | 181.67 | 75.30 |
| P/B ratio | 4.90 | 2.50 |
Profitability
| Metric | AFJK | DTSQ |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | 5.15% | 4.75% |
| ROIC | -5.83% | -4.17% |
Frequently asked
- Which has the lower trailing P/E, AFJK or DTSQ?
- DTSQ has the lower trailing P/E: AFJK trades at 181.67 and DTSQ at 75.30. P/E is one valuation measure and does not by itself establish which business is cheaper.
Go deeper
Dig into the metrics
Aimei Health Technology P/E ratioDT Cloud Star Acquisition P/E ratioAimei Health Technology ROEDT Cloud Star Acquisition ROEAimei Health Technology operating marginDT Cloud Star Acquisition operating marginAimei Health Technology revenue growthDT Cloud Star Acquisition revenue growthAimei Health Technology free cash flowDT Cloud Star Acquisition free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.